A lavender body lotion reaches the final review before launch. The fragrance supplier’s statement lists linalool at a percentage of the fragrance oil; the formula adds lavender essential oil for its own sake, and the ingredient list ends with one familiar word: Parfum. The question on the table is narrow and numerical. Does any listed allergen exceed 10 mg/kg in the finished lotion?

Since July 31, 2026, new cosmetics placed on the European Union (EU) market have had to name an expanded list of fragrance allergens above set thresholds, and Canada began applying the same list to new products on August 1, 2026. In the United States, Congress mandated fragrance allergen labeling in 2022, but the FDA has not yet proposed the rule that would define it. For brands, labs, and contract research organizations, the result is the same: The word “fragrance” no longer settles the label on its own.

Key Takeaways

  • The EU list expanded in 2023. Regulation (EU) 2023/1545 added 56 fragrance allergens to Annex III of the Cosmetics Regulation. Health Canada describes the result as 81 entries.
  • Thresholds depend on product type. An allergen must be labeled above 0.001% (10 mg/kg) in leave-on products and 0.01% (100 mg/kg) in rinse-off products in both the EU and Canada.
  • Deadlines have passed for new products. The EU’s placing-on-market date was July 31, 2026, and Canada’s date for new products was August 1, 2026. Existing products in both markets have until 2028.
  • The U.S. rule is still pending. MoCRA requires fragrance allergen labeling, but FDA had not published its proposed rule as of November 17, 2026. The Unified Agenda targets November 2026.
  • GC-MS is the core method, but sample preparation is the hard part. EN 16274 and the IFRA method quantify up to 57 allergens in ready-to-inject fragrance materials. Finished products require validated extraction and controls for matrix effects and co-elution.

What Are Fragrance Allergens? Why Do Labels Name Them?

A fragrance allergen is a fragrance or flavor substance that can cause allergic contact dermatitis in sensitized people and that a regulator requires to be named individually on the ingredient list above a set concentration. Health Canada’s regulations define the term almost exactly that way, tying it to the substances that Annex III of the EU Cosmetics Regulation flags for labeling.

The list grew from dermatology, not from marketing. The 2026 review in Applied Sciences traces the original 26 labeled substances to a 1999 opinion of the EU’s Scientific Committee on Cosmetic Products and Non-Food Products. The expansion that followed rests on the 2012 SCCS opinion cited in Regulation (EU) 2023/1545. Two of the original 26, lyral and lilial, have since been banned outright and moved to Annex II of the Cosmetics Regulation.

The label line serves a specific reader. According to the European Commission, individual labeling helps consumers who are already sensitized to particular allergens identify and avoid them. The Commission also states plainly that an allergen’s appearance in the list does not mean the product is unsafe.

What Does EU Regulation 2023/1545 Require?

The European Union already required individual labeling of a short list of fragrance allergens. Commission Regulation (EU) 2023/1545 lengthened that list. It amends Annex III of the Cosmetics Regulation, Regulation (EC) No 1223/2009, and entered into force on August 16, 2023.

The expansion rests on science the Commission requested more than a decade earlier. According to the regulation’s recitals, the Scientific Committee on Consumer Safety (SCCS) adopted an opinion in June 2012 that confirmed the existing labeled allergens remained relevant. The same opinion identified 56 additional fragrance allergens that had clearly caused allergies in humans.

The European Commission’s fragrance allergen labeling page summarizes the result. The regulation adds individual labeling requirements for those 56 allergens. It also updates existing entries, grouping certain substances and revising their identification information.

Thresholds

The trigger for labeling depends on product type rather than on the allergen. An Annex III fragrance allergen must appear in the ingredient list when its concentration exceeds:

  • 0.001% in leave-on products such as creams, lotions, and perfumes, which equals 10 mg/kg
  • 0.01% in rinse-off products such as shampoos and shower gels, which equals 100 mg/kg

The European Commission’s fragrance allergen labeling page confirms both percentages. The mg/kg values are unit conversions, since 1% equals 10,000 mg/kg, and the DIN listing for EN 16274 expresses 0.001% the same way, as 10 mg/kg. The product examples are illustrative. Health Canada’s labeling guide defines a leave-on product as one intended to stay in prolonged contact with the skin, hair, or mucous membranes, and a rinse-off product as one intended to be removed after application.

Below the thresholds, an allergen can remain within “parfum” or “aroma” on the label.

Transition Dates

The Commission states that, since July 31, 2026, cosmetic products that do not meet the new requirements may no longer be placed on the EU market. Products placed on the market before that date may still be made available until July 31, 2028.

Why Reported Totals Differ

Trade coverage describes the expanded list as 80, 81, or 82 allergens. The Commission’s own page describes the change as 56 additions plus grouped and revised entries. Health Canada, which adopts the same Annex III list, describes the result as an expansion from 24 to 81 entries. “Entries” is the key word: a single entry such as Rose Flower Oil/Extract can cover ten botanical ingredients. Annex III to Regulation (EC) No 1223/2009 remains the legally binding list, and the Commission’s CosIng database offers informative, non-binding ingredient lookups.

How Has Canada Changed Its Cosmetic Regulations?

Canada did not write its own allergen list. Instead, the amended Cosmetic Regulations incorporate by reference the fragrance allergens in Annex III of the EU Cosmetics Regulation, “as amended from time to time.” As a result, future EU additions can carry into Canadian requirements without a separate Canadian list.

Health Canada’s Industry Guide for the Labelling of Cosmetics sets out the phase-in. The thresholds match the EU’s: 0.001% in leave-on products and 0.01% in rinse-off products.

DateProducts coveredAllergens to disclose
April 12, 2026New and existing cosmetics24 allergens (List 1)
August 1, 2026New cosmetics81 entries (List 2)
August 1, 2028Existing products81 entries (List 2)

The guide adds three details that matter for testing. First, an allergen must be disclosed outside the term “parfum” regardless of its function in the product, even when it arrives as part of a botanical extract. Second, manufacturers and importers must also list disclosed allergens in section 5 of the Cosmetic Notification Form.

Third, grouped entries follow a summation rule. Disclosure applies when the combined concentration of all substances in a grouped entry exceeds the threshold. Health Canada’s own example pairs 0.0008% Rosa Damascena Flower Oil with 0.002% Rosa Damascena Flower Extract in a leave-on product. Neither alone tells the full story, but their sum passes 0.001%, so “Rose Flower Oil/Extract” must appear on the label.

List 2 also groups eight lavender oils and extracts under the single label name “Lavandula Oil/Extract.”

Where Does the US Stand?

Status as of November 17, 2026. FDA has not yet proposed its fragrance allergen rule, so no federal label requirement for individual fragrance allergens is in effect.

The mandate itself is law. The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) added section 609(b) to the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. 364e. It requires the responsible person to identify each fragrance allergen on a cosmetic’s label. The statute leaves the definition to FDA, which must determine by regulation which substances count.

Congress also told FDA where to look. In writing the rule, FDA must consider international, state, and local allergen disclosure requirements, including the substance and format of the EU’s, and it may set threshold levels for disclosure.

FDA missed MoCRA’s June 29, 2024, deadline for the proposed rule. The reginfo.gov entry for RIN 0910-AI90, titled “Disclosure of Fragrance Allergens in Cosmetic Labeling,” now lists a target of November 2026 for the proposal. Its abstract says FDA is proposing to identify certain substances as fragrance allergens and to require their disclosure on cosmetic labels.

Until a final rule takes effect, the existing ingredient labeling regulation governs. Under 21 CFR 701.3(a), ingredients appear in descending order of predominance, “except that fragrance or flavor may be listed as fragrance or flavor.”

California’s Reporting Requirement

One U.S. requirement already reaches individual fragrance allergens, although it governs reporting rather than labels. California’s Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2020 took effect on January 1, 2022. It requires companies to report cosmetics sold in the state that contain reportable fragrance and flavor ingredients to the California Safe Cosmetics Program.

According to the program’s compliance FAQ, fragrance allergens on its Reportable Ingredients List must be reported at or above 0.01% in rinse-off products and 0.001% in leave-on products. Those values match the EU thresholds, although California’s wording (“at or above”) differs from the EU’s (“exceeds”).

How Do Labs Test for Fragrance Allergens?

Fragrance allergens are volatile or semi-volatile and thermally stable, which makes gas chromatography the natural separation tool. A 2026 review in Applied Sciences covering methods published from 2015 to 2025 describes GC paired with mass spectrometry (GC-MS), or tandem MS (GC-MS/MS), as the dominant approach for identification and quantification. CL’s guide to the different types of chromatography covers the separation principles in more depth.

The Standardized Methods

Two reference methods anchor most allergen panels. Both start from a “ready-to-inject” sample, which matters more than it first appears.

  • EN 16274. The European Committee for Standardization (CEN/TC 347) first published this GC-MS method in 2012 for 24 allergens. According to the DIN listing of the 2012 edition, it pairs two GC columns of different polarity and quantifies each allergen above 0.001% (10 mg/kg). The 2021 revision extends the list to 57 suspected allergens in fragrance compounds and fragrance raw materials, and was validated at IFRA and CEN level.
  • The IFRA analytical method. The International Fragrance Association’s method for 57 suspected allergens and their isomers targets concentrations above 0.002% (20 mg/kg) in ready-to-inject fragrance raw materials and oils. It runs two analyte sets on two columns of differing polarity, for four GC-MS runs in total. A collaborative validation study published in Flavour and Fragrance Journal in 2023 evaluated the method across laboratories.

The ready-to-inject starting point is also the main limitation of both methods. The 2026 review notes that standardized methods are limited to ready-to-inject samples, and that the 2021 revision did not substantially change sample preparation. Creams, lotions, lipsticks, and shampoos therefore need a validated extraction step before any of these methods apply.

Why the Finished Product Is Harder

Cosmetic matrices are heterogeneous: emulsions, waxes, surfactants, and pigments all travel with the analytes. Those components can suppress or enhance the instrument’s response, an effect known as the matrix effect.

Matrix effects can be large. In a liquid-liquid extraction GC-MS study published in the Journal of Food and Drug Analysis, Lu and colleagues quantified fragrance allergens across lotions, creams, perfumes, deodorants, shampoos, and shower gels. The 2026 review reports that this method’s matrix effect for cinnamyl alcohol reached 162.5%, and that a later ultrasound-assisted extraction method reduced it to 7%. Labs address the problem with matrix-matched calibration, internal standards, cleanup steps, or more selective detection such as GC-MS/MS.

Co-Elution and Isomers

Separation is the other recurring problem. Fragrance allergens can co-elute with structurally similar compounds, with their own isomers, or with matrix components.

The regulations build isomer chemistry into the list itself. Health Canada’s Appendix 1 groups geranial and neral under “Citral,” and groups alpha-damascone, damascenone, and delta-damascone as “Rose Ketones.” A method that resolves the isomers must still report their combined total against the threshold. The review also cites a market surveillance study of perfumes in which matrix co-elution led to overestimation of up to 30-fold for some analytes, and concludes that validation with solvent standards alone does not reflect real samples.

Natural Extracts and Reference Materials

Two further gaps shape what a lab can report. First, the standardized methods target chemically defined substances, while the expanded Annex III list also names botanical oils and extracts. The 2026 review counts 28 natural extracts among the entries. An essential oil such as lavender is a mixture rather than a single peak, so supplier composition data and botanical identity testing become part of the evidence. CL’s guide to essential oil testing and its Outsource! Week coverage of detecting adulterants with chiral GC-MS cover that side of the work.

Second, the review identifies the limited availability of matrix-matched certified reference materials as an open challenge. Most methods are validated with standard solutions or fortified samples, which may not capture every analyte-matrix interaction.

Supplier Data or Finished-Product Testing?

The label decision rests on one number: each allergen’s concentration in the finished product. Brands typically reach that number by calculation, by measurement, or by both.

Calculation From Supplier Data

Fragrance houses usually report allergen content as a percentage of the fragrance compound, not of the final formula. The finished-product figure follows from the dose. For example, a fragrance oil that contains 0.5% linalool, dosed at 1% in a lotion, contributes 0.005% linalool to the lotion. That equals 50 mg/kg, five times the EU leave-on threshold of 10 mg/kg.

Supplier statements do not always capture every source of an allergen. Health Canada’s guide states that an allergen must be disclosed regardless of its function in the product, even when it arrives inside a botanical extract. An essential oil added for skin feel, or a citrus extract added for its claimed benefits, can therefore contribute limonene or linalool outside the fragrance compound. For grouped entries, the guide also requires the concentrations of all substances in the group to be summed.

Measurement in the Finished Product

Analytical testing measures what the finished product actually contains, from every source at once. It also carries the constraints described above: a validated extraction for the specific matrix, quantitation limits comfortably below 10 mg/kg for leave-on products, and controls for co-elution and matrix effects.

Where Regulators Place the Responsibility

Neither the EU nor Canada prescribes a single route. The European Commission’s guidance page places the obligation on manufacturers, responsible persons, and other economic operators. It lists reviewing fragrance ingredients, determining whether any Annex III allergen exceeds the thresholds, and keeping the product information file and safety assessment consistent with composition and labeling.

Whichever route a brand uses, the result typically ends up in quality documentation. Our guide to the Certificate of Analysis (COA) explains how analytical results are reported. Fragrance allergens also arise across product categories that CL has covered, including soap, household and industrial cleaning products, and cosmetics formulation testing under MoCRA.

Connect on Contract Laboratory

Contract Laboratory connects cosmetic, fragrance, and personal care brands with laboratories that perform fragrance allergen analysis, GC-MS panels, essential oil testing, and related cosmetic testing.

  • Submit a Request to describe your fragrance allergen or cosmetic testing needs and receive responses from qualified labs.
  • View Requests to see current testing requests from brands and manufacturers.
  • Register Your Lab to list your laboratory’s capabilities and respond to testing requests.

Sources and Further Reading

Frequently Asked Questions (FAQs)

1. What is a fragrance allergen?

A fragrance allergen is a fragrance or flavor substance that can cause allergic contact dermatitis in sensitized people and that regulators require to be named individually on a cosmetic’s ingredient list above a set concentration. In the EU and Canada, the list comes from Annex III of Regulation (EC) No 1223/2009.

2. How many fragrance allergens must be labeled in the EU?

Regulation (EU) 2023/1545 added 56 allergens to the existing list. Health Canada, which adopts the same Annex III list, counts 81 entries. Some entries group several substances or botanical ingredients under one label name, which is why published totals vary.

3. What are the labeling thresholds?

In the EU and Canada, an allergen must be labeled when it exceeds 0.001% (10 mg/kg) in leave-on products or 0.01% (100 mg/kg) in rinse-off products. For grouped entries, Health Canada applies the threshold to the sum of the substances in the group.

4. Does the US require fragrance allergen labeling today?

Not yet at the federal level. MoCRA requires it, but FDA must first define fragrance allergens by regulation. Until a final rule takes effect, 21 CFR 701.3(a) permits fragrance to be listed as “fragrance.” California separately requires companies to report fragrance allergens in products sold in the state.

5. When will FDA propose its fragrance allergen rule?

The Unified Agenda entry for RIN 0910-AI90 lists November 2026 as the target for the proposal. MoCRA’s statutory deadline was June 29, 2024. As of November 17, 2026, no proposed rule had appeared in the Federal Register.

6. Which analytical methods do labs use for fragrance allergens?

GC-MS and GC-MS/MS are the dominant techniques. EN 16274:2021 and the IFRA analytical method quantify up to 57 suspected allergens and their isomers in ready-to-inject fragrance materials. Finished cosmetics require an additional validated extraction step.

7. Can supplier data replace finished-product testing?

The EU and Canadian rules do not prescribe one route. Supplier data reports allergen content in the fragrance compound, which brands convert to a finished-product concentration by dose. Finished-product testing measures allergens from all sources at once, including botanical ingredients outside the fragrance, which Health Canada states must also be counted.

Author

  • Swathi Kodaikal, MSc, holds a master’s degree in biotechnology and has worked in places where actual science and research happen. Blending her love for writing with science, Swathi enjoys demystifying complex research findings for readers from all walks of life. On the days she's not writing, she learns and performs Kathak, sings, makes plans to travel, and obsesses over cleanliness.

    View all posts